Zinner elected chair of American College of Surgeons board of regents

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MICHAEL ZINNER was elected chair of the Board of Regents of the American College of Surgeons.

Zinner is a general surgeon with expertise in pancreatic-hepatobiliary diseases. Since 2016, he has been the founding chief executive officer and executive medical director of the Miami Cancer Institute–Baptist Health South Florida.

Prior to that time, he served as surgeon-in-chief and Moseley Professor of Surgery at the Brigham and Women’s Hospital and Harvard Medical School. During this time, Zinner also served as clinical director and chief of surgical services at the Dana-Farber/Brigham and Women’s Cancer Center.

A fellow of the American College of Surgeons (FACS) since 1983, Zinner has previously served as vice-chair of the ACS Board of Regents (2010-2015) and chair of the ACS Board of Governors (2008-2010).

YOU MAY BE INTERESTED IN

FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA. 
In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login